Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Aspen Aerogels (ASPN) over the last 12 years, with Q3 2025 value amounting to $69000.0.

  • Aspen Aerogels' Gains from Investment Securities fell 9708.86% to $69000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $949000.0, marking a year-over-year decrease of 8188.59%. This contributed to the annual value of $5.1 million for FY2024, which is 5056.84% down from last year.
  • As of Q3 2025, Aspen Aerogels' Gains from Investment Securities stood at $69000.0, which was down 9708.86% from $46000.0 recorded in Q2 2025.
  • Over the past 5 years, Aspen Aerogels' Gains from Investment Securities peaked at $9.5 million during Q2 2023, and registered a low of -$2.8 million during Q4 2022.
  • Over the past 5 years, Aspen Aerogels' median Gains from Investment Securities value was $1.1 million (recorded in 2021), while the average stood at $1.6 million.
  • Per our database at Business Quant, Aspen Aerogels' Gains from Investment Securities soared by 4001875.0% in 2021 and then crashed by 24270.57% in 2022.
  • Quarter analysis of 5 years shows Aspen Aerogels' Gains from Investment Securities stood at $2.0 million in 2021, then crashed by 242.71% to -$2.8 million in 2022, then soared by 113.65% to $386000.0 in 2023, then fell by 27.98% to $278000.0 in 2024, then crashed by 75.18% to $69000.0 in 2025.
  • Its last three reported values are $69000.0 in Q3 2025, $46000.0 for Q2 2025, and $556000.0 during Q1 2025.